Today in Medicine
SEE OTHER BRANDS

Fresh medicine news from the world

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.

Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Approval is based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity EC approval follows positive CHMP opinion, MHRA conditional marketing...

knēNest® Wins 'Product of the Week' on The Grommet, Earning National Recognition and Major Momentum

knēNest® Wins 'Product of the Week' on The Grommet, Earning National Recognition and Major Momentum

knēNest® delivers pain relief and alignment for side sleepers creating nationwide buzz. SHERIDAN, WY, UNITED STATES, July 21, 2025 /⁨EINPresswire.com⁩/ -- The revolutionary knee pillow designed specifically for side-sleepers, knēNest®, has...

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to...

Warehouse Management Systems Market Growing at 16.3% CAGR | Reach USD 12.3 Billion by 2031 Globally

Warehouse Management Systems Market Growing at 16.3% CAGR | Reach USD 12.3 Billion by 2031 Globally

WILMINGTON, DE, UNITED STATES, July 21, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a new report, titled, "Warehouse Management Systems Market Growing at 16.3% CAGR | Reach USD 12.3 Billion by 2031 Globally." The report offers an...

Facial Recognition Market Reach USD 24.3 Billion by 2032 Growing at 16.4% CAGR Globally

Facial Recognition Market Reach USD 24.3 Billion by 2032 Growing at 16.4% CAGR Globally

WILMINGTON, DE, UNITED STATES, July 21, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a new report, titled, "Facial Recognition Market Reach USD 24.3 Billion by 2032 Growing at 16.4% CAGR Globally." The report offers an extensive...

Arizona Imaging Group Southwest Medical Imaging Achieves 89% Script Upload Success with ScriptAid by Cranberry Peak

Arizona Imaging Group Southwest Medical Imaging Achieves 89% Script Upload Success with ScriptAid by Cranberry Peak

Southwest Medical Imaging used Cranberry Peak’s ScriptAid SaaS to streamline script collection. 275+ staff onboarded in 2 weeks, 85% uploaded <5 min. CAMBRIDGE, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Southwest Medical Imaging...

Grady Campbell Announces The 2025 TOP 50 Investment Banks in the Middle Market™

Grady Campbell Announces The 2025 TOP 50 Investment Banks in the Middle Market™

CHICAGO, IL, UNITED STATES, July 21, 2025 /⁨EINPresswire.com⁩/ -- Grady Campbell, a leading middle market branding and marketing firm, is pleased to announce the 2025 TOP 50 Investment Banks in the Middle Market™. The TOP 50 Investment Banks in...

Applicator Recall: Integra LifeSciences Removes MicroMyst Applicators Due to Potential Sterility Concerns

Applicator Recall: Integra LifeSciences Removes MicroMyst Applicators Due to Potential Sterility Concerns

This recall involves removing devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product Manufacturer's Product...

USPTO Grants Patent for Novel Therapeutics for Antibody-Cannabinoid Conjugates

USPTO Grants Patent for Novel Therapeutics for Antibody-Cannabinoid Conjugates

Diverse Biotech Emerging as Leader in Cannabinoid Drug Conjugate Space With Landmark Patent MIAMI, FL, UNITED STATES, July 21, 2025 /⁨EINPresswire.com⁩/ -- Diverse Biotech Inc., an innovative developer in novel drug technology, today announced a...

Core One Med's Workflow Optimization Drives Efficiency for Busy Medical Practices

Core One Med's Workflow Optimization Drives Efficiency for Busy Medical Practices

Healthcare technology company helps practices cut administrative time by 40% while improving patient care delivery IRVINE, CA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Medical practices across the country are discovering a...

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

MARIETTA, Ga., July 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”)...

Carnitine Supplements Market Is Expected To Reaching Nearly USD 316.5 Million By 2031 | CAGR of 5.1%

Carnitine Supplements Market Is Expected To Reaching Nearly USD 316.5 Million By 2031 | CAGR of 5.1%

A significant rise in the prevalence of obesity and excess weight gain across most of the developed & developing economies drive the growth of the global market WILMINGTON, DE, UNITED STATES, July 21, 2025 /⁨EINPresswire.com⁩/ -- Carnitine...

Russia’s naval ‘Smolny’ makes second stop in Equatorial Guinea

Russia’s naval ‘Smolny’ makes second stop in Equatorial Guinea

(MENAFN) The Russian naval training ship Smolny has made its second official stop in Equatorial Guinea, marking the beginning of its latest international voyage, according to reports. Part of the Baltic Fleet, the vessel was welcomed in Malabo by...

Attorney General Bonta Sues Trump Administration Over Cruel Directive Unlawfully Restricting Access to Head Start, Other Public Benefit Programs

Attorney General Bonta Sues Trump Administration Over Cruel Directive Unlawfully Restricting Access to Head Start, Other Public Benefit Programs

Statute and longstanding federal policy have allowed access, regardless of immigration status, to specific community programs, including those deemed necessary for protection of life or safety OAKLAND – California Attorney General Rob Bonta today...

Russian Warship Makes Second Visit to Equatorial Guinea

Russian Warship Makes Second Visit to Equatorial Guinea

(MENAFN) The Russian naval training vessel Smolny has arrived in Equatorial Guinea for its second formal visit, according to a report by a news agency on Sunday. This ship is part of Russia’s Baltic Fleet and was welcomed in the capital city of...

Hours to Change at Disaster Recovery Centers in Tennessee

Hours to Change at Disaster Recovery Centers in Tennessee

Middle and Western Tennesseans who experienced damage from the April 2-24 severe storms can get in-person assistance at FEMA Disaster Recovery Centers. The deadline to apply for assistance is Aug. 19. Money is available for survivors who need help...

Thin Film Chip Resistor Market Projected to Garner Significant Revenues By 2031

Thin Film Chip Resistor Market Projected to Garner Significant Revenues By 2031

Thin Film Chip Resistor Market Expected to Reach $1.1 Billion by 2031 — Allied Market Research WILMINGTON, DE, UNITED STATES, July 21, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research, in a report titled "Thin Film Chip Resistor Market," states...

How a Hidden Hand of Hepatic Signaling Could Help Fight Metabolic Disease

How a Hidden Hand of Hepatic Signaling Could Help Fight Metabolic Disease

New research identifies PTPRD as a key regulator of metabolic liver disease – making it a potential target for treating diseases such as MASLD and MASH. CHINA, July 21, 2025 /⁨EINPresswire.com⁩/ -- Chronic liver diseases tied to metabolic...

Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy

Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy

BOSTON and KANSAS CITY, Kan., July 15, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, and its clinical...

Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531

Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531

– Mean weight loss of 19.2% at 6 mg with no plateau in 48-week Phase 3 trial – – Favorable safety profile consistent with other GLP-1-based treatments – – Hengrui to submit NDA in China; Kailera plans to evaluate both higher doses and longer...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service